Durham, North Carolina, United States Catalysta Ventures appeared to be the VC, which was created in 2010. The main department of described VC is located in the Durham. The venture was found in North America in United States.
Among the various public portfolio startups of the fund, we may underline PhaseBio Pharmaceuticals For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Medical Device, Medical.
The typical case for the fund is to invest in rounds with 1 participant. In the next rounds fund is usually obtained by Johnson & Johnson Development Corporation, Hatteras Venture Partners, Fletcher Spaght, Inc..
The top amount of exits for fund were in 2018. The high activity for fund was in 2002. The fund is constantly included in less than 2 deals per year.
Funds with similar focus
| Fund Name | Location |
| 10X Capital | - |
| 2EP | - |
| Dansk Erhvervsinvestering | Copenhagen, Denmark, Hovedstaden |
| EIR Ventures | Stockholm, Stockholm County, Sweden |
| Exome Asset Management | New York, New York, United States |
| Intuit | California, Mountain View, United States |
| Jincheng Boshi | Beijing, Beijing, China |
| Kansas City Equity Partners | Kansas City, Missouri, United States |
| Orbit Venture Partners | - |
| Provident Capital | Gurgaon, Haryana, India |
| Quantum Pacific Capital | China, Hong Kong, Hong Kong Island |
| Ridgeline Ventures | Boulder, Colorado, United States |
| Rukam Capital Trust | Kyonggi-do, Seongnam, South Korea |
| Salesforce | California, San Francisco, United States |
| Shenzhen Lanshi Venture Capital | China, Guangdong, Shenzhen |
| Start'Act | Gabès, Tunis, Tunisia |
| Telos Impact | Belgium, Brussels, Brussels Hoofdstedelijk Gewest |
| Vidici Ventures | - |
| Vinci Partners | Brazil, Rio de Janeiro, Rio De Janeiro |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
PhaseBio Pharmaceuticals | 25 Feb 2002 | Pennsylvania, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
PhaseBio Pharmaceuticals | 25 Feb 2002 | Pennsylvania, United States |
